Appetite suppression from GLP-1 Agonists

Appetite suppression is defined as the experience of a distinct decrease in a person's sense of hunger and appetite in a manner which can result in both a lesser desire to eat food and a decreased enjoyment of its taste. This typically results in the person going for prolonged periods without eating, and depending on the intensity, can manifest as anything from a mild disinterest in food to a sense of complete revulsion at the thought of consuming anything. At its most intense, attempting to eat may produce physical discomfort such as nausea, difficulty swallowing, or a feeling that one's stomach has physically shrunk.

The subjective experience of appetite suppression differs from simply not being hungry. While normal satiation is a comfortable absence of hunger, substance-induced appetite suppression often involves an active aversion to food where the very idea of eating feels wrong or unappealing. Users frequently report that they can intellectually recognize they should eat, and may even attempt to do so, but find that food tastes bland, textures feel unpleasant in the mouth, and swallowing requires conscious effort. This disconnect between knowing one needs to eat and being unable to comfortably do so is a hallmark of the experience.

Appetite suppression is most commonly induced under the influence of stimulant compounds such as amphetamines, methylphenidate, cocaine, and MDMA, where it is one of the most reliable and consistent effects. The mechanism typically involves the release or reuptake inhibition of catecholamines, particularly norepinephrine and dopamine, which suppress hunger signals from the hypothalamus. It also frequently occurs with psychedelic compounds such as LSD and psilocybin, where the intense cognitive and perceptual experience simply overwhelms normal bodily awareness including hunger. Opioids, certain antidepressants, and nicotine also commonly produce this effect.

The duration of appetite suppression often extends well beyond the primary effects of the substance. With stimulants, users may find their appetite suppressed for 8-12 hours or more, spanning the entire active period and into the comedown. This extended suppression is one of the primary mechanisms by which chronic stimulant use can lead to significant weight loss and nutritional deficiency over time. The effect is often accompanied by other physical symptoms such as dry mouth, dehydration, and nausea that further discourage eating.

Subjective reports consistently describe the challenge of forcing oneself to eat during stimulant use. Many experienced users develop strategies such as preparing food before dosing, consuming smoothies or liquid nutrition that is easier to swallow, or setting timed reminders to eat. The importance of maintaining nutritional intake during extended substance use cannot be overstated, as the combination of appetite suppression, increased metabolic demand from stimulation, and dehydration can quickly deplete the body's resources.

Appetite suppression is often accompanied by other effects such as stimulation, dry mouth, nausea, and dehydration. While the effect itself is not directly dangerous in short-term use, persistent appetite suppression from regular substance use can lead to malnutrition, muscle wasting, weakened immune function, and other serious health consequences. It is also the primary mechanism behind the use of certain substances as weight-loss aids, a practice that carries significant risks of dependence and adverse health outcomes.